Why are leukoerythroblastic cells observed on a peripheral blood smear, and what are all possible causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Leukoerythroblastic Blood Picture: Mechanism and Comprehensive Causes

A leukoerythroblastic blood picture occurs when bone marrow architecture is disrupted or stressed, forcing premature release of immature myeloid precursors (metamyelocytes, myelocytes, promyelocytes, blasts) and nucleated red blood cells into peripheral circulation, often accompanied by teardrop cells in myelofibrotic conditions.

Why This Occurs: Pathophysiologic Mechanisms

The appearance of leukoerythroblastic cells reflects three primary mechanisms:

  • Marrow infiltration/replacement: Space-occupying processes physically disrupt normal marrow architecture, forcing immature cells into circulation
  • Marrow stress/stimulation: Severe hemolysis, hemorrhage, or infection triggers compensatory hematopoiesis with premature cell release
  • Marrow fibrosis: Architectural distortion from fibrotic processes prevents normal cell maturation and orderly release

Complete Differential Diagnosis

Malignant Causes (Most Common)

Primary Hematologic Malignancies

  • Myeloproliferative neoplasms - particularly primary myelofibrosis 1
  • Acute myeloid leukemia - especially with myelodysplasia-related changes 2
  • Myelodysplastic syndromes - particularly with fibrosis or high blast counts 1, 3
  • Chronic myelomonocytic leukemia 1
  • Juvenile myelomonocytic leukemia - important pediatric cause 4, 5
  • Plasma cell leukemia - when >20% circulating plasma cells 6

Metastatic Solid Tumors (Second Most Common Malignant Cause)

  • Breast carcinoma - most frequent solid tumor cause 4, 7
  • Prostate carcinoma 4, 7
  • Lung carcinoma 4, 7
  • Gastric carcinoma 4
  • Neuroblastoma - particularly in children 5
  • Any metastatic carcinoma to bone marrow 7

Clinical Pearl: In malignant disease, leukoerythroblastosis indicates disease progression and portends poor survival 4. Bone marrow necrosis from extensive marrow involvement carries median survival <1 month 7.

Hemolytic Diseases

  • Severe hemolytic anemia - any cause with marked compensatory erythropoiesis 4
  • Rh incompatibility/hemolytic disease of newborn - can present with dramatic leukoerythroblastosis 8
  • Sickle cell disease - particularly during vaso-occlusive crisis 9
  • Autoimmune hemolytic anemia - when severe

Infectious Causes

  • Severe bacterial sepsis 4
  • Parvovirus B19 infection - especially in neonates/infants causing intrauterine infection 5
  • COVID-19 infection - emerging cause with adverse prognostic significance 10, 9
  • Infectious mononucleosis 6
  • Tuberculosis - disseminated/miliary
  • Fungal infections - disseminated

Important Caveat: Distinguish from benign reactive plasmacytosis in serum sickness, which can mimic plasma cell leukemia 6. Flow cytometry demonstrating clonality is essential.

Hemorrhagic Causes

  • Acute severe hemorrhage - triggers compensatory marrow response 4
  • Chronic blood loss - when severe enough to stress marrow

Bone Marrow Disorders

  • Primary myelofibrosis - classic cause with teardrop cells 1
  • Secondary myelofibrosis - from any cause
  • Bone marrow necrosis - associated with severe bone pain, hypercalcemia, and extremely poor prognosis 7
  • Osteopetrosis - important pediatric cause 4, 5

Other Causes

  • Medications - certain drugs can trigger marrow stress 5
  • Hypoxic stress - severe chronic hypoxemia
  • Pregnancy complications - particularly in sickle cell patients 9

Diagnostic Approach Algorithm

Step 1: Confirm leukoerythroblastosis on peripheral smear

  • Document immature myeloid cells (metamyelocytes, myelocytes, promyelocytes, blasts)
  • Count nucleated RBCs
  • Look for teardrop cells (suggest myelofibrosis)
  • Assess for circulating plasma cells

Step 2: Immediate clinical correlation

  • Check for fever/sepsis (infection)
  • Assess for severe anemia symptoms (hemolysis/hemorrhage)
  • Examine for bone pain without radiographic findings (marrow necrosis) 7
  • Palpate for splenomegaly/hepatomegaly (malignancy)
  • Review medication history

Step 3: Essential laboratory workup 2, 11

  • Complete blood count with differential
  • Lactate dehydrogenase (elevated suggests malignancy or hemolysis)
  • Comprehensive metabolic panel
  • Reticulocyte count (elevated in hemolysis/hemorrhage)
  • Coagulation studies (DIC screening)
  • Direct antiglobulin test (if hemolysis suspected)

Step 4: Bone marrow examination 1, 2, 12, 11

  • Bone marrow aspirate and biopsy are mandatory - peripheral blood alone is insufficient 13
  • Morphologic examination with iron stain
  • Flow cytometry immunophenotyping
  • Cytogenetics (karyotype with FISH)
  • Molecular testing (FLT3, NPM1, CEBPA, IDH1/2, TP53, JAK2) 2

Step 5: Additional studies based on initial findings

  • If malignancy suspected: PET/CT for staging 2
  • If plasma cells present: flow cytometry to confirm clonality 6
  • If infection suspected: blood cultures, viral serologies (parvovirus B19, COVID-19) 10, 5
  • If hemolysis: hemolysis panel, hemoglobin electrophoresis

Critical Pitfalls to Avoid

  1. Do not assume benign cause without bone marrow examination - malignancy is the most common cause in adults 4, 7

  2. Do not confuse with benign reactive conditions - polyclonal plasma cells can appear in serum sickness, infectious mononucleosis, and severe sepsis 6. Flow cytometry demonstrating clonality is essential.

  3. Do not delay bone marrow biopsy - peripheral blood analysis alone is inadequate 13. First bone marrow draw (1-3 mL) should go to cytogenetics to avoid hemodilution 12.

  4. Recognize bone marrow necrosis urgency - severe bone pain without radiographic abnormality suggests marrow necrosis with median survival <1 month 7

  5. In COVID-19 patients, leukoerythroblastosis appears to be an adverse prognostic marker - 58% mortality in one series 10. Follow-up smears on day 7 may guide management decisions.

  6. In neonates, consider parvovirus B19 and Rh incompatibility - these can present with dramatic leukoerythroblastosis and premature delivery 8, 5

Prognostic Significance

Leukoerythroblastosis in malignant disease indicates advanced disease with poor survival 4. When associated with bone marrow necrosis, prognosis is particularly grave with median survival <1 month, though rare responses to chemotherapy with marrow healing have been reported 7.

In non-malignant causes (hemolysis, infection), prognosis depends on the underlying condition and its treatability. The finding itself resolves with treatment of the primary disorder 8, 5.

References

Guideline

myelodysplastic syndromes: clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

Guideline

acute myeloid leukemia, version 3.2019, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

Research

Systematic review about etiologic association to the leukoerythroblastic reaction.

International journal of laboratory hematology, 2020

Research

Bone marrow necrosis.

The American journal of medicine, 1976

Research

Leukoerythroblastosis - An unsusal presentation of COVID 19 infection.

Clinical epidemiology and global health, 2022

Related Questions

What does a leukoerythroblastic reaction indicate and what is the recommended work‑up?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What does a deep S wave in lead II indicate and how should it be evaluated?
Which medications can produce an alcohol-like effect without causing adverse side effects?
In a patient with methylphenidate (Ritalin) overdose who is intubated, has decreased level of consciousness and tachycardia, what is the appropriate supportive management for the sympathomimetic effects, including heart rate control with esmolol?
Given MRI findings of diffuse disc bulges from L1 to S1 causing ventral thecal sac effacement, mild mass effect on exiting nerve roots, and moderate to severe bilateral foraminal narrowing (especially at L1‑L2 and L4‑L5), what does this mean and is surgery indicated for the L1 exiting nerve root?
In a male patient with a CHADS‑VASc score of 1 and a history of non‑valvular paroxysmal atrial fibrillation, which direct oral anticoagulant is preferred for prescribing?
What is physiologic anemia of infancy, including typical age of onset, expected hemoglobin nadir, and recommended management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.